Daniels AB, Liu GT, Volpe NJ, Galetta SL, Moster ML, Newman NJ, et al. Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol. 2007;143(4):635–41. https://doi.org/10.1016/j.ajo.2006.12.040.
Grech O, Mollan SP, Wakerley BR, Alimajstorovic Z, Lavery GG, Sinclair AJ. Emerging themes in idiopathic intracranial hypertension. J Neurol. 2020;267(12):3776–84. https://doi.org/10.1007/s00415-020-10090-4.
Article PubMed PubMed Central Google Scholar
Thurtell MJ, Wall M. Idiopathic intracranial hypertension (pseudotumor cerebri): recognition, treatment, and ongoing management. Curr Treat Options Neurol. 2013;15(1):1–12. https://doi.org/10.1007/s11940-012-0207-4.
Article PubMed PubMed Central Google Scholar
Kilgore KP, Lee MS, Leavitt JA, Mokri B, Hodge DO, Frank RD, et al. Re-evaluating the incidence of idiopathic intracranial hypertension in an era of increasing obesity. Ophthalmology. 2017;124(5):697–700. https://doi.org/10.1016/j.ophtha.2017.01.006.
Mollan SP, Mytton J, Tsermoulas G, Sinclair AJ. Idiopathic intracranial hypertension: evaluation of admissions and emergency readmissions through the hospital episode statistic dataset between 2002–2020. Life (Basel). 2021;11(5):417. https://doi.org/10.3390/life11050417.
Ghaffari-Rafi A, Mehdizadeh R, Ko AWK, Ghaffari-Rafi S, Leon-Rojas J. Idiopathic intracranial hypertension in the United States: demographic and socioeconomic disparities. Front Neurol. 2020;11:869. https://doi.org/10.3389/fneur.2020.00869.
Article PubMed PubMed Central Google Scholar
Shaia JK, Sharma N, Kumar M, Chu J, Maatouk C, Talcott K, et al. Changes in prevalence of idiopathic intracranial hypertension in the United States between 2015 and 2022, stratified by sex, race, and ethnicity. Neurology. 2024;102(3):e208036. https://doi.org/10.1212/WNL.0000000000208036.
Article PubMed PubMed Central Google Scholar
Sinclair AJ, Burdon MA, Nightingale PG, Ball AK, Good P, Matthews TD, et al. Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. BMJ. 2010;341:c2701. https://doi.org/10.1136/bmj.c2701.
Article PubMed PubMed Central Google Scholar
Mollan SP, Davies B, Silver NC, Shaw S, Mallucci CL, Wakerley BR, et al. Idiopathic intracranial hypertension: consensus guidelines on management. J Neurol Neurosurg Psychiatry. 2018;89(10):1088–100. https://doi.org/10.1136/jnnp-2017-317440.
Leek JC, Arif H. Pregnancy medications. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. Available from: http://www.ncbi.nlm.nih.gov/books/NBK507858/. Accessed 4/2/2025.
Alves S, Sousa N, Cardoso LÍ, Alves J. Multidisciplinary management of idiopathic intracranial hypertension in pregnancy: case series and narrative review. Brazilian Journal of Anesthesiology (English Edition). 2022;72(6):790–4. https://doi.org/10.1016/j.bjane.2021.02.030.
Gurney SP, Ramalingam S, Thomas A, Sinclair AJ, Mollan SP. Exploring the current management idiopathic intracranial hypertension, and understanding the role of dural venous sinus stenting. Eye Brain. 2020;12:1–13. https://doi.org/10.2147/EB.S193027.
Article PubMed PubMed Central Google Scholar
Barkatullah AF, Leishangthem L, Moss HE. MRI findings as markers of idiopathic intracranial hypertension. Curr Opin Neurol. 2021;34(1):75–83. https://doi.org/10.1097/WCO.0000000000000885.
Article PubMed PubMed Central Google Scholar
Ibrahim YA, Mironov O, Deif A, Mangla R, Almast J. Idiopathic intracranial hypertension: diagnostic accuracy of the transverse dural venous sinus attenuation on CT scans. Neuroradiol J. 2014;27(6):665–70. https://doi.org/10.15274/NRJ-2014-10086.
Article PubMed PubMed Central Google Scholar
Jain C. ACOG committee opinion no. 723: guidelines for diagnostic imaging during pregnancy and lactation. Obstet Gynecol. 2019;133(1):186–186. https://doi.org/10.1097/AOG.0000000000003049.
Thaller M, Wakerley BR, Abbott S, Tahrani AA, Mollan SP, Sinclair AJ. Managing idiopathic intracranial hypertension in pregnancy: practical advice. Pract Neurol. 2022;22(4):295–300. https://doi.org/10.1136/practneurol-2021-003152.
Article PubMed PubMed Central Google Scholar
Poole D, Citerio G, Helbok R, Ichai C, Meyfroidt G, Oddo M, et al. Evidence for mannitol as an effective agent against intracranial hypertension: an individual patient data meta-analysis. Neurocrit Care. 2020;32(1):252–61. https://doi.org/10.1007/s12028-019-00771-y.
Article PubMed CAS Google Scholar
Reitman E, Flood P. Anaesthetic considerations for non-obstetric surgery during pregnancy. Br J Anaesth. 2011;107(Suppl 1):i72–8. https://doi.org/10.1093/bja/aer343.
Bandoli G, Palmsten K, Forbess Smith CJ, Chambers CD. A review of systemic corticosteroid use in pregnancy and the risk of select pregnancy and birth outcomes. Rheum Dis Clin North Am. 2017;43(3):489–502. https://doi.org/10.1016/j.rdc.2017.04.013.
Article PubMed PubMed Central Google Scholar
Kim KT. Lumbar puncture: considerations, procedure, and complications. Encephalitis. 2022;2(4):93–7. https://doi.org/10.47936/encephalitis.2022.00045.
Article PubMed PubMed Central Google Scholar
Higgins JNP, Owler BK, Cousins C, Pickard JD. Venous sinus stenting for refractory benign intracranial hypertension. Lancet. 2002;359(9302):228–30. https://doi.org/10.1016/S0140-6736(02)07440-8.
Townsend RK, Jost A, Amans MR, Hui F, Bender MT, Satti SR, et al. Major complications of dural venous sinus stenting for idiopathic intracranial hypertension: case series and management considerations. J Neurointerv Surg. 2022;14(1):neurintsurg-2021-017361. https://doi.org/10.1136/neurintsurg-2021-017361.
Sharma M, Chhabra A, Raina N. Optic nerve sheath fenestration: a second lease at sight. Indian J Ophthalmol. 2023;71(7):2845–9. https://doi.org/10.4103/IJO.IJO_3027_22.
Article PubMed PubMed Central Google Scholar
Byth LA, Lust K, Jeffree RL, Paine M, Voldanova L, Craven A-M. Management of idiopathic intracranial hypertension in pregnancy. Obstet Med. 2022;15(3):160–7. https://doi.org/10.1177/1753495X211021333.
Adesina O, Patel BC. Optic nerve decompression. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. Available from: http://www.ncbi.nlm.nih.gov/books/NBK538300/. Accessed 23 Apr 2025.
Coyte RM, Darrah T, Olesik J, Barrett E, O’Connor TG, Brunner J, et al. Gadolinium during human pregnancy following administration of gadolinium chelate before pregnancy. Birth Defects Res. 2023;115(14):1264–73. https://doi.org/10.1002/bdr2.2209.
Article PubMed PubMed Central CAS Google Scholar
Yoon I, Slesinger TL. Radiation exposure in pregnancy. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. Available from: https://www.ncbi.nlm.nih.gov/books/NBK551690/. Accessed 6/6/2025.
David AL, Spencer RN. Clinical assessment of fetal well‐being and fetal safety indicators. J Clin Pharmacol. 2022;62(S1). https://doi.org/10.1002/jcph.2126.
Expert Panel on Women’s Imaging:, Shipp TD, Zelop CM, Maturen KE, Deshmukh SP, Dudiak KM, et al. ACR appropriateness criteria® growth disturbances-risk of fetal growth restriction. J Am Coll Radiol. 2019;16(5S):S116–25. https://doi.org/10.1016/j.jacr.2019.02.009.
Simpson L, Khati NJ, Deshmukh SP, Dudiak KM, Harisinghani MG, Henrichsen TL, et al. ACR appropriateness criteria assessment of fetal well-being. J Am Coll Radiol. 2016;13(12 Pt A):1483–93. https://doi.org/10.1016/j.jacr.2016.08.028.
ACOG Committee Opinion No. 762: Prepregnancy counseling. Obstet Gynecol. 2019;133(1):e78–89. https://doi.org/10.1097/AOG.0000000000003013.
Eksi M, Ögrenci A, Batçık O, Koban O. Management of obstructive hydrocephalus in pregnant patient. Asian J Neurosurg. 2018;13(1):123–7. https://doi.org/10.4103/1793-5482.181127.
Comments (0)